OTCMKTS:WXXWY WuXi Biologics (Cayman) (WXXWY) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free WXXWY Stock Alerts $3.43 +0.03 (+0.88%) (As of 05/1/2024 ET) Add Compare Share Share Today's Range$3.40▼$3.4750-Day Range$3.19▼$5.2752-Week Range$3.12▼$13.25Volume49,508 shsAverage Volume255,697 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get WuXi Biologics (Cayman) alerts: Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About WuXi Biologics (Cayman) Stock (OTCMKTS:WXXWY)WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development, and manufacturing in the People's Republic of China, North America, Europe, and internationally. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and material supplier activities. The company has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.Read More WXXWY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WXXWY Stock News HeadlinesApril 29, 2024 | prnewswire.comWuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability CommitmentApril 26, 2024 | seekingalpha.comWuXi Biologics: Staying On The SidelinesMay 1, 2024 | Porter & Company (Ad)Trump just won 2024President Trump signed an executive order that ensures he’ll be remembered as one of America’s greatest Presidents. It was an Executive Order that received almost no media attention…April 26, 2024 | americanbankingnews.comWuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Down 84.7% in AprilApril 25, 2024 | finance.yahoo.comAstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'April 16, 2024 | finance.yahoo.comWuXi Biologics (Cayman) Inc (1FW1.SG)April 2, 2024 | markets.businessinsider.comWuxi Biologics: A Strong Buy Based on Robust Sales Growth, Strategic Expansion, and Financial StabilityMarch 26, 2024 | prnewswire.comWuXi Biologics Reports Solid 2023 Annual ResultsMay 1, 2024 | Porter & Company (Ad)Trump just won 2024President Trump signed an executive order that ensures he’ll be remembered as one of America’s greatest Presidents. It was an Executive Order that received almost no media attention…March 22, 2024 | prnewswire.comWuXi Biologics Named to CDP 'A List' for Water SecurityMarch 8, 2024 | msn.comHong Kong Stocks: WuXi Biologics Shares Tumble on US Biotech Bill ConcernsMarch 5, 2024 | finance.yahoo.comWuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change AssessmentFebruary 21, 2024 | prnewswire.comWuXi Biologics Recognized as Both Industry and Regional ESG Top-Rated Company by Morningstar SustainalyticsFebruary 14, 2024 | markets.businessinsider.comWuxi Biologics: Navigating the Biosecure Act with Resilience and OptimismJanuary 31, 2024 | finance.yahoo.comWuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in IrelandJanuary 30, 2024 | markets.businessinsider.comWuxi Biologics (Cayman) Buy Rating: Growth Potential and Strong Compliance StandardsJanuary 28, 2024 | bloomberg.comWuXi Bio Denies Military Ties After Shares Slumped on US BillJanuary 26, 2024 | finance.yahoo.comWuXi AppTec, Wuxi Bio Tumble as US Lawmakers Propose BanJanuary 26, 2024 | finance.yahoo.comUS lawmaker moves bill to ban Chinese biotech firms from federal contracts, alleging complicity with militaryJanuary 26, 2024 | finance.yahoo.comChinese Biotech Stocks Plunge on Proposed U.S. LegislationJanuary 24, 2024 | finance.yahoo.comWuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC EffectJanuary 23, 2024 | finance.yahoo.comWuXi Biologics (Cayman) Inc. (WXXWY)January 23, 2024 | morningstar.comWuXi Biologics (Cayman) Inc ADR WXXWYJanuary 17, 2024 | finance.yahoo.comWuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBody™January 12, 2024 | markets.businessinsider.comWuxi Biologics: A Buy Rating on Robust Growth and Strong Pipeline ProspectsJanuary 10, 2024 | finance.yahoo.comWuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product CandidatesJanuary 8, 2024 | finance.yahoo.comWuXi Biologics to Increase Manufacturing Capacity in MassachusettsSee More Headlines Receive WXXWY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WuXi Biologics (Cayman) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:WXXWY CUSIPN/A CIKN/A Webwww.wuxibiologics.com.cn Phone8651081831205FaxN/AEmployees12,740Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Ge Li Ph.D. (Age 57)Founder & Chairman Dr. Zhisheng Chen (Age 51)CEO & Executive Director Comp: $621.73kDr. Weichang Zhou Ph.D. (Age 60)Honorary President of Global Biologics Development, Senior Advisor to CEO & Non-Executive Director Comp: $417.66kMr. Ming Tu (Age 56)CFO & Executive VP Ms. Tang Shaogui M.B.A.VP and Head of Global Communications, Operations & ESGDr. Sherry Gu (Age 53)Chief Technology Officer and Executive VP of Global Biologics Development Department Dr. Jijie Gu (Age 58)Executive VP & Chief Scientific Officer Ms. Eileen WangIR Senior DirectorMs. Cong Ding J.D.VP & Head of Legal DepartmentHe WangChief Compliance Officer, Senior VP and Head of Global Compliance & Risk ManagementMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors WXXWY Stock Analysis - Frequently Asked Questions How have WXXWY shares performed in 2024? WuXi Biologics (Cayman)'s stock was trading at $7.45 at the beginning of the year. Since then, WXXWY stock has decreased by 54.0% and is now trading at $3.43. View the best growth stocks for 2024 here. Are investors shorting WuXi Biologics (Cayman)? WuXi Biologics (Cayman) saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 9,200 shares, a drop of 84.7% from the March 31st total of 60,300 shares. Based on an average trading volume of 222,600 shares, the days-to-cover ratio is presently 0.0 days. View WuXi Biologics (Cayman)'s Short Interest. How do I buy shares of WuXi Biologics (Cayman)? Shares of WXXWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:WXXWY) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing4 coins to be the “Next Bitcoin”True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi Biologics (Cayman) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
